首页> 外国专利> Functional screening and screening system of cervical cancer chemotherapy

Functional screening and screening system of cervical cancer chemotherapy

机译:宫颈癌化疗的功能筛选和筛选系统

摘要

The present invention relates to a method for producing a plasmid pRSV-luc comprising a RSV promoter gene inducing activity of human Papillomavirus (HPV) 16 type E6 protein and a reporter gene encoding a luciferase protein, To produce a SiHa / pRSV-luc cell line (KCTC 04227BP) and to provide a system for retrieving the survival performance of the HPV type 16 E6 protein. In addition, the present invention has an excellent effect that can be used for screening and screening for the efficacy of anticancer agents for cervical cancer by treating the expression of HPV 16 type E6 protein by treating an anticancer agent of cervical cancer with SiHa / pRSV-luc cell line.
机译:本发明涉及产生质粒pRSV-luc的方法,该质粒包含诱导人乳头瘤病毒(HPV)16型E6蛋白的RSV启动子基因活性和编码荧光素酶蛋白的报道基因,以生产SiHa / pRSV-luc细胞系。 (KCTC 04227BP),并提供一种检索HPV 16型E6蛋白的存活性能的系统。另外,通过用SiHa / pRSV-治疗宫颈癌的抗癌剂来治疗HPV 16型E6蛋白的表达,本发明具有可用于筛选和筛查宫颈癌的抗癌剂的功效的优异效果。 luc细胞系。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号